SCHEMBL869781

SCHEMBL869781

CC(C)(C)OC(=O)N1CCC(CCn2cc(-c3ccc4c(c3)CCN4C(=O)Cc3cc(F)ccc3F)c3c(N)ncnc32)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK3 Q9NZJ5 14/20 0.68
EIF2AK2 P19525 2/20 0.55
RIPK1 Q13546 5/20 0.53
MAPK13 O15264 1/20 0.52
ABL1 P00519 1/20 0.52
NTRK1 P04629 1/20 0.52
LCK P06239 1/20 0.52
FYN P06241 1/20 0.52
YES1 P07947 1/20 0.52
LYN P07948 1/20 0.52
RET P07949 1/20 0.52
MET P08581 1/20 0.52
HCK P08631 1/20 0.52
FGR P09769 1/20 0.52
KIT P10721 1/20 0.52
FGFR1 P11362 1/20 0.52
SRC P12931 1/20 0.52
FLT1 P17948 1/20 0.52
EPHA2 P29317 1/20 0.52
EPHA8 P29322 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2374671 0.91 EIF2AK3 (0.66) EIF2AK3EIF2AK2RIPK1MAPK13ABL1
SCHEMBL868648 0.89 EIF2AK3 (0.69) EIF2AK3EIF2AK2ABL1SRCABL2
SCHEMBL868848 0.88 EIF2AK3 (0.72) EIF2AK3EIF2AK2RIPK1MAPK13ABL1
SCHEMBL869974 0.84 EIF2AK3 (0.80) EIF2AK3EIF2AK2RIPK1EIF2AK1
SCHEMBL869000 0.83 EIF2AK3 (0.80) EIF2AK3EIF2AK2RIPK1EIF2AK1
SCHEMBL868634 0.82 EIF2AK3 (1.00) EIF2AK3EIF2AK2RIPK1NTRK1LCK
SCHEMBL868429 0.81 EIF2AK3 (0.76) EIF2AK3EIF2AK2RIPK1EIF2AK1
SCHEMBL868471 0.80 EIF2AK3 (0.80) EIF2AK3EIF2AK2RIPK1EIF2AK1
SCHEMBL2374504 0.80 EIF2AK3 (0.67) EIF2AK3EIF2AK2RIPK1EIF2AK1
SCHEMBL14579041 0.79 EIF2AK3 (0.70) EIF2AK3EIF2AK2RIPK1MAPK13ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549868-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-01-07 EP disclosed
US-8598156-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2013-12-03 US disclosed
US-20130018038-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2013-01-17 US disclosed
US-20120077828-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018038-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R EIF2AK3 16/4885EIF2AK2 174/4885RIPK1 218/4885
US-20120077828-A1 CHEMICAL COMPOUNDS BRCA1, IRS1, IGF1R EIF2AK3 16/4885EIF2AK2 174/4885RIPK1 218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.